BBHC
MDCO

Brown Brothers Harriman & Co’s Medicines Co MDCO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-83
Closed -$3K – 917
2016
Q4 		$3K Hold
83
– – ﹤0.01% 820
2016
Q3 		$3K Hold
83
– – ﹤0.01% 739
2016
Q2 		$3K Buy
+83
New +$2.93K ﹤0.01% 774

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Brown Brothers Harriman & Co's MDCO Position: Q1 2017 in Review

Brown Brothers Harriman & Co sold out of Medicines Co (MDCO) in Q1 2017, closing a stake of 83 shares — an estimated $3K sold.

Brown Brothers Harriman & Co first reported a position in MDCO in Q2 2016 and held it in 3 quarters. The position peaked at $3K in Q4 2016. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

  • Brown Brothers Harriman & Co reported no remaining Medicines Co position as of Q1 2017 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 83 Medicines Co shares in Q1 2017, an estimated $3K.
  • Brown Brothers Harriman & Co first reported a position in Medicines Co in Q2 2016 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's Medicines Co position peaked at $3K in Q4 2016.
  • 220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2017, filed 12 May 2017.